Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-24-138403
Filing Date
2024-12-19
Accepted
2024-12-19 15:47:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7892
  Complete submission text file 0000950170-24-138403.txt   9833
Mailing Address BLOCKS A & B, PORTWAY BUILDING GRANTA PARK, GREAT ABINGTON CAMBRIDGE X0 CB21 6GS
Business Address BLOCKS A & B, PORTWAY BUILDING GRANTA PARK, GREAT ABINGTON CAMBRIDGE X0 CB21 6GS 011441223261503
BICYCLE THERAPEUTICS PLC (Subject) CIK: 0001761612 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91023 | Film No.: 241563108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address GOOIMEER 2-35 NAARDEN P7 1411 DC
Business Address GOOIMEER 2-35 NAARDEN P7 1411 DC 31 35 699 30 00
Forbion Growth Opportunities Fund II Cooperatief U.A. (Filed by) CIK: 0001936623 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G